Nanotechnology for targeted delivery in cancer therapeutics

International Journal of Pharmaceutical Sciences Review and Research

Volumn 1, Issue 1, 2010, Pages 1-7

  Pal, Dilipkumar ^a   Nayak, Amit Kumar ^a  

^a SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Cancer therapy; Nanoparticle; Nanotechnology; Targeted delivery

Indexed keywords

CARBON NANOTUBE; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; FULLERENE DERIVATIVE; GOLD NANOPARTICLE; LIPOSOME; LURTOTECAN; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; NANOSHELL; NANOWIRE; PLATINUM COMPLEX; QUANTUM DOT; SOLID LIPID NANOPARTICLE; VINCRISTINE;

BREAST CANCER; CANCER RESISTANCE; CANCER THERAPY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG SPECIFICITY; EDITORIAL; HUMAN; KAPOSI SARCOMA; MOLECULARLY TARGETED THERAPY; MULTIDRUG RESISTANCE; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PARTICLE SIZE; SOLID TUMOR;

EID: 79952020769     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (52)

1. Kumar B, Yadav PR, Goel HC, Moshahid M, Rizvi A, Recent developments in cancer therapy by the use of nanotechnology, Digest J Nanomater Biostr, 4(1), 2009, 1-12.
2. Pal DK, Diet and cancer, The J North Orissa Univ, 2(1), 2003, 77-80.
3. Carelle N, Piotto E, Bellanger A, Germanaud J, Thuiller A, Khayat D, Changing patient perceptions of side effects of cancer chemotherapy, Cancer, 95, 2002, 155-63.
4. O'connor R, The pharmacology of cancer resistance, Anticancer Res, 27, 2007, 1267-72.
5. Higgins CF, Multiple molecular mechanisms for multidrug resistance transports, Nature, 446, 2007, 749-57.
6. Convreur P, Vauthier C, Nanotechnology: Intelligent design to treat complex disease, Pharm Res, 27(7), 2006, 1417-1450.
7. Haley B, Frenkel E, Nanoparticles for drug delivery in cancer treatment, Urol Oncol, 26(1), 2008, 57-64.
8. Sing J, Tremendous potential for cancer treatment: Nanotechnology, The Indian Pharmacist, 8, 2008, 23-26.
9. Torchilin VP, Targeted pharmaceutical nanocarriers for cancer therapy and imaging, AAPS J, 9(2), 2007, Article 15: E128-147.
10. Loo C, Lin A, Hirsch L, Lee M, Marton J, Halas N, West J, Drezek R, Nanoshell-enabled photonicsbased imaging and therapy of cancer, Technol Cancer Res Treat, 2004, 91-110.
11. Baker JR, Quintana A Jr, Pehlerel L, Banazak-Holl al M, Tomalia D, Raczka E, The synthesis and testing of anti- cancer therapeutic nanodevices, Biomed Microdevices, 3(1), 2001, 61-9.
12. Bawa R, Patents and nanomedicine, Nanomed: Nanotech Biol Med, 2, 2007, 351-74.
13. Farokhzad OC, Langer R, Nanomedicine: Developing smarter therapeutic and diagnostic modalities, Adv Drug Deliv Rev, 58, 2006, 1456-9.
14. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA, Emerging nano pharmaceuticals, Nanomed: Nanotech Biol Med, 4, 2008, 273-82.
15. Wang X, Wang Y, Chen Z, Shin DM, Advances of cancer therapy by nanotechnology, Cancer Res Treat, 41(1), 2009, 1-11.
16. Ferrari M, Cancer nanotechnology: Opportunities and challenges, Nat Rev Cancer, 5, 2005, 161-71.
17. Arayne MS, Sultana N, Qureshi F, Nanoparticles in drug delivery of cardiovascular drugs, Pak J Pharm Sci, 20(4), 2007, 340-8.
18. Park JW, Liposome-based drug delivery in breast cancer treatment, Breast Cancer Res, 4, 2002, 95-9.
19. Kataoka K, Harada A, Nagasaki Y, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv Drug Deliv Rev, 43, 2001, 113-31.
20. Nishiyama N, Kataoka K, Current state, achievements and future prospects of polymeric micelles as nanocarriers for drug and gene delivery, Pharmacol Ther, 112, 2006, 630-48.
21. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC, Block copolymer micelles: Preparation, characterization and application in drug delivery, J Control Release, 109, 2005, 169-88.
22. Nishiyama N, Kataoka K, Nanostructured devices based on block copolymers assemblies for drug delivery: designing structures for enhanced drug function, Adv Polym Sci, 193, 2006, 67-101.
23. Bay Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K, Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH triggered drug releasing properties for active intracellular drug delivery, Mol Biosyst, 1, 2005, 242-50.
24. Wagner E, Programmed drug delivery for tumor targeting, Expert Opin Biol Ther, 7, 2007, 587-93.
25. Shi W, Sahoo Y, Swihert MP, Prasad PN, Gold nanoshells on polystyrene cores for control surface plasmon resonance, Langmuir, 21, 2005, 1610-17.
26. West JL, Halas NJ, Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics, Annu Rev Biomed Eng, 5, 2003, 285-92.
27. Kewal K, Jain T, Jain KK, Review nanotechnology in clinical laboratory diagnostics, Clinica Chimica Acta, 358, 2005, 37-54.
28. Mansoori GA, Mohazzabi P, McCormack P, Jabbari S, Nanotechnology in cancer prevention, detection and treatment: bright future lies ahead, World Rev Sci, Tech Sust Dev, 4(2/3), 2007, 226-57.
29. Moghimi SM, Hunter AC, Murray JC, Longcirculating and target-specific nanoparticles: theory to practice, Pharmacol Rev, 53(2), 2001, 283-318.
30. Meheta RM, Thakral S, Fullerenes: An introduction and overview of their biological properties, Indian J Pharm Sci, 68(1), 2006, 13-9.
31. Lacerda L, Bianco A, Prato M, Kastarelos K, Carbon nanotubes as nanomedicines: From toxicology to pharmacology, Adv Drug Deliv Rev, 58, 2006, 1460-70.
32. McDevitt MR, Chattopadhyay D, Kappel BJ, Jaggi JS, Schiffman SR, Antczak C, Njardarson JT, Brentjeus R, Scheinberg DA, Tumor targeting with antibody functionalized radiolabelled carbon nanotubes, J Nucl Med, 48, 2007, 1180-9.
33. Vogtle F, Buhleier E, Wehner W, Cascade- and Nonskid- chain- like synthesis of molecular activity, Topologies Synth, 1978, 155-8.
34. Pushkar S, Philip A, Pathak K, Pathak D, Dendrimers: Nanotechnology derived novel polymers in drug delivery, Indian J Pharm Edu Res, 40(3), 2006, 153-8.
35. Wolinsky JB, Grinstaff MW, Therapeutic and diagnostic applications of dendrimers for cancer treatment, Adv Drug Deliv Rev, 60, 2008, 1037-55.
36. Kobayashi H, Sato N, Saga T, Nakamoto Y, Ishimori T, Toyama S, Togashi K, Konishi J, Brechbiel MW, Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity, Eur J Nucl Med, 27, 2000, 1334-9.
37. Patri AK, Thomas T, Baker JR Jr., Bander NH, Antibody-dendrimer conjugates for targeted prostate cancer therapy, Polym Mater Sci Eng, 86, 2002, 130.
38. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mulé J, Baker JR Jr., Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor, Pharm Res, 19(9), 2001, 1310-6.
39. Kaji N, Tokeshi M, Baba Y, Quantum dots for single biomolecule imaging, Anal Sci, 23, 2007, 21-4.
40. Smith AM, Gao X, Nie S, Quantum-Dot nanocrystals for in vivo molecular and cellular imaging, Photochem Photobiol, 80, 2004, 377-85.
41. Gao X, Cui Y, Levenson RM, Chung LW, Nie S, In vivo cancer targeting and imaging with semiconductor quantum dots, Nat Biotechnol, 22, 2004, 969-76.
42. Derfus AM, Chan WCW, Bhatia SN, Probing the cytotoxicity of semiconductor quantum dots, Nano Lett, 4, 2004, 11-8.
43. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S, In vivo molecular and cellular imaging with quantum dots, Curr Opin Biotechnol, 16, 2005, 63-72.
44. Ghosh P, Han G, Dey M, Kim CK, Rotello VM, Gold nanoparticles in drug delivery applications, Adv Drug Deliv Rev, 60, 2008, 1307-15.
45. Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY, Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles, Adv Drug Deliv Rev, 59, 2007, 491-504.
46. Zheng G, Patolsky F, Lieber CM. Nanowire biosensors: a tool for medicine and life science. Nanomed: Nanotech Biol Med, 2(4), 2006, 277.
47. Moffat BA, Reddy GR, McConville, P, Hall DE, Chenevert TL, Kopelman RR, Philbert M, Weissleder R, Rehemtulla A, Ross BD, A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI, Molecular Imaging, 2(4), 2001, 324-32.
48. Curtis J, Greenberg M, Kester J, Philips S, Krieger G, Nanotechnology and toxicology: a primer for clinicians, Toxicol Sci, 25(4), 2006, 245-60.
49. Moghimi SM, Hunter AC, Murray JC, Nanomedicine: Current status and future prospects, FASEB J, 19(3), 2005, 311-30.
50. Duffin R, Mills NL, Donaldson K, Nanoparticles-a thoracic toxicology perspective, Yonsei Med J, 48(4), 2007, 561-72.
51. Paciotti GE, Mayer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L, Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery, Drug Deliv, 2004; 115-21.
52. Italia JL, Bhat DK, Bharadwaj V, Tikoo K, Kumar MN, PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to sandimmune Neoral, J Control Release, 119(2), 2007, 197-206.